| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |